Providence Regional Medical Center Everett

Everett, Washington 98201-1689

6 studies enrolling now · 44 studies all time

What they study most

Abdominal Aortic Aneurysm, Acute Coronary Syndrome, Advanced Non-small Cell Lung Cancer (NSCLC), Aorto-iliac Aneurysm, Appendicitis, Atrial Fibrillation, Bleeding, Breast Cancer, COVID-19, Carcinoma, Non-Small-Cell Lung, Cardiac Arrest, Out-Of-Hospital, Cardiac Resynchronization Therapy

Studies at this site

• A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer — Recruiting now
• A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events — Recruiting now
• A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older — Recruiting now
• The TELENEO Trial: A Multicenter Trial of Telemedicine for Advanced Neonatal Resuscitations in Community Hospitals — Recruiting now
• Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction — Recruiting now
• The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19 — Recruiting now
• CHAMPION-AF Clinical Trial — Running, not enrolling
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Running, not enrolling
• Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients — Completed
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• Study of Obeldesivir to Treat Nonhospitalized Adults With Acute Respiratory Syncytial Virus (RSV) Infection — Stopped early
• Understanding the Long-term Impact of COVID-19 in Adults (RECOVER) — Completed
• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304) — Stopped early
• FlowTriever All-Comer Registry for Patient Safety and Hemodynamics — Completed
• A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1) — Stopped early
• Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients — Completed
• Continuing Access to Axitinib (A406- AG- 013736 ) For Patients Previously Receiving AG 013736 In Clinical Trials — Completed
• Phase IIB TL + YCWP + DC in Melanoma — Completed
• Tucatinib Plus Trastuzumab in Patients With HER2+ Colorectal Cancer — Completed
• Comparative Effectiveness of Direct Admission & Admission Through Emergency Departments for Children — Completed
• JOURNEY II XR Safety and Effectiveness PMCF — Running, not enrolling
• Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study — Completed
• Meth-OD: A Study of IXT-m200 in Patients With Toxicity From Methamphetamine Overdose — Stopped early
• ABSORB III Randomized Controlled Trial (RCT) — Completed
• Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19) — Stopped early
• The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial — Completed
• Predictive Assay for Decision Making in Adjuvant Therapy — Stopped early
• Precision Event Monitoring for Patients With Heart Failure Using HeartLogic — Completed
• Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study — Completed
• Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation — Completed
• Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting — Stopped early
• XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients. — Completed
• ENABLE MRI (Magnetic Resonance Imaging) — Completed
• Evaluation of ACUITY™ X4 Quadripolar Coronary Venous Leads and RELIANCE™ 4-FRONT Defibrillation Leads — Completed
• Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) — Completed
• Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer — Completed
• PRediction of Opioid-induced Respiratory Depression In Patients Monitored by capnoGraphY — Completed
• Zenith® Spiral-Z® AAA Iliac Leg Graft Post-market Registry — Completed
• Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer — Completed
• A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC — Stopped early